RNS Number : 0705O
Nanosynth Group PLC
29 September 2023
 

29 September 2023

 

nanosynth group plc

("nanosynth", the "Company" or the "Group")

 

Accounts Update

 

nanosynth announces that the Company will not be in a position to publish its interim financial statements for the period ended 30 June 2023 ("Interim Results") by 30 September 2023, being the deadline provided by Rule 18 of the AIM Rules for Companies.

 

The Company is currently preparing the full year results for the year ended 31 December 2022 and Interim Results, and it is anticipated that these will be released together.

 

The Company continues to consider potential funding options for the business.

 

Trading in the Company's shares on AIM will remain suspended and further announcements will be made in due course as appropriate.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR') which has been incorporated into UK law by the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.

 

 

ENQUIRIES:

 

 

nanosynth group plc

 

 

 

via IFC Advisory

Financial PR

IFC Advisory Ltd

+44 20 3934 6630

Graham Herring


Zach Cohen

 

 


Nominated Adviser and Broker

S.P Angel Corporate Finance LLP

+44 20 3470 0470

Stuart Gledhill


Kasia Brzozowska

 


Joint Broker

Peterhouse Capital Limited

Duncan Vasey

+44 20 7469 0930

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFERARITFIV